About 200 reports

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2021, provides an overview of the Influenza A Virus, H7N9 Subtype...

  • Influenza
  • Drug Development
  • World
  • China
  • Netherlands
  • Drug Approval
  • Infectious Disease Mortality

Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections - Drugs In Development, 2021, provides an overview of the Influenza A Virus, H3N2 Subtype...

  • Influenza
  • Drug Development
  • World
  • Netherlands
  • Vaccination Coverage
  • Drug Approval

Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections - Drugs In Development, 2021, provides an overview of the Influenza A Virus, H1N1 Subtype...

  • Influenza
  • Drug Development
  • World
  • United States
  • Netherlands
  • Vaccination Coverage
  • Drug Approval

Pandemic Influenza - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Pandemic Influenza - Global Clinical Trials Review, H2, 2021" provides an overview of Pandemic Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Pandemic...

  • Influenza
  • Clinical Trial
  • World
  • Medical Technology Density
  • Hospital Admission

Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - Drugs In Development, 2021, provides an overview of the Influenza A Virus, H5N1 Subtype...

  • Influenza
  • Drug Development
  • World
  • Netherlands
  • South Africa
  • Vaccination Coverage
  • Drug Approval

The global influenza diagnostics market is projected to reach USD 1.1 billion by 2026 from USD 0.8billion in 2021, at a CAGR of 7.7% during the forecast period. Market growth is driven by factors such as the growth in influenza research for diagnostic technologies,rising demand for rapid disease diagnosis and increasing prevalence of influenza....

  • Diagnostics
  • Influenza
  • World
  • United States
  • North America
  • APAC
  • Influenza Prevalence
  • Health Expenditure

China’s demand for Cold and Flu Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Influenza
  • China
  • Industrial Production
  • Labour Force

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2020, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious...

  • Influenza
  • World
  • Drug Approval
  • Prescription Drug Sales

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious...

  • Influenza
  • World
  • Netherlands
  • Health Provider Density
  • Drug Approval

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2020, provides an overview of the Influenza A Virus, H3N2 Subtype Infections (Infectious...

  • Influenza
  • World
  • Netherlands
  • India
  • Drug Approval
  • Elderly Population

Major players in the influenza diagnostics market are F. Hoffmann-La Roche Ltd., Quidel Corporation, ?h?rm? F??h?r, Abbott Laboratories, Hologic, Becton Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience Inc. and GenMark Diagnostics. The global influenza diagnostic market is expected to grow from $1.75...

  • Diagnostics
  • Influenza
  • Molecular Diagnostics
  • World
  • APAC

Influenza Medications market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Influenza Medications Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Influenza Medications types, applications. Further, Influenza...

  • Influenza
  • World

Major players in the influenza diagnostic market are F. Hoffmann-La Roche Ltd, Quidel Corporation, ?h?rm? F??h?r, Abbott Laboratories, Hologic, Becton, Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience, Inc., and GenMark Diagnostics. The global influenza diagnostic market is expected to grow from $1.31...

  • Diagnostics
  • Influenza
  • Molecular Diagnostics
  • World
  • APAC

Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2020, provides an overview of the Influenza A Virus, H7N9 Subtype Infections (Infectious...

  • Influenza
  • World
  • China
  • Netherlands
  • Drug Approval
  • Pharmaceutical Registrations

Influenza Medications Market Report Overview Influenza Medications market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Influenza Medications market types and applications. It is a focused study on Influenza Medications market space including...

  • Influenza
  • World
  • Health Provider Density

Abstract: - Global Cold and Flu Supplements Market to Reach $20.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cold and Flu Supplements estimated at US$14.3 Billion in the year 2020, is projected to reach a revised size of US$20.7 Billion by 2027, growing at a CAGR of 5.4% over the analysis period...

  • Influenza
  • World
  • China
  • United States

Abstract: - Global Influenza Diagnostics Market to Reach $3.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Influenza Diagnostics estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027....

  • Diagnostics
  • Cell Therapy
  • Influenza
  • World
  • China
  • United States

Abstract: - Global Influenza Medication Market to Reach $1.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Influenza Medication estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 0.4% over the analysis period 2020-2027....

  • Influenza Antiviral
  • Influenza
  • World
  • China
  • United States

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2020, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious...

  • Influenza
  • World
  • Netherlands
  • Drug Approval
  • Vaccination Coverage

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2020, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious...

  • Influenza
  • Drug Approval
  • Vaccination Coverage

Abstract: - Global Over the Counter (OTC) Drugs Market to Reach $210.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Over the Counter (OTC) Drugs estimated at US$146.3 Billion in the year 2020, is projected to reach a revised size of US$210.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis...

  • Dermatology
  • Analgesic
  • Influenza
  • World
  • China
  • United States

Haemophilus influenzae Type B Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Haemophilus influenzae Type B Infections - Pipeline Review, H1 2020, provides an overview of the Haemophilus influenzae Type B Infections (Infectious Disease)...

  • Influenza
  • World
  • Drug Approval
  • Pharmaceutical Production

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2020, provides an overview of the Influenza A Virus, H3N2 Subtype Infections (Infectious...

  • Influenza
  • World
  • China
  • India
  • Netherlands
  • Vaccination Coverage
  • Drug Approval

Global Influenza Diagnostics Market 2021-2025 The analyst has been monitoring the influenza diagnostics market and it is poised to grow by $ 401.89 mn during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Our report on influenza diagnostics market provides a holistic analysis, market size and forecast,...

  • Diagnostics
  • Influenza
  • World

Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021 Summary Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Pandemic Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Influenza
  • Infectious Disease
  • World

Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021 Summary Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Seasonal Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Influenza
  • Infectious Disease
  • World

Influenza M2 Proton Channel - Drugs in Development, 2021 Summary Influenza M2 Proton Channel - Drugs in Development, 2021 provides in depth analysis on Influenza M2 Proton Channel targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications,...

  • Influenza
  • Research And Development
  • Drug Development
  • World

Influenza A H5N1 Infection Pipeline Overview The Q4 Influenza A H5N1 Infection pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Influenza A H5N1 Infection, provides an update on the mechanism of action and targets,...

  • Influenza
  • Netherlands
  • World

Influenza B Infections Pipeline Overview The Q4 Influenza B Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Influenza B Infections, provides an update on the mechanism of action and targets, licensing...

  • Influenza
  • World

Major players in the influenza diagnostic market are F. Hoffmann-La Roche Ltd, Quidel Corporation, ?h?rm? F??h?r, Abbott Laboratories, Hologic, Becton, Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience, Inc., and GenMark Diagnostics. The global influenza diagnostics market is expected to grow from $1.14...

  • Diagnostics
  • Influenza
  • Molecular Diagnostics
  • World